BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This Notice is to inform the market of the decision of West Essex Clinical Commissioning Group to award a contract to its secondary mental health provider, Essex Partnership University NHS Foundation Trust (EPUT), to deliver an ADHD Assessment and Treatment Service across West Essex.
EPUT are commissioned through their current secondary mental health contract to assess / treat patients for ADHD where there is a comorbid secondary mental healthcare need. However, a commissioning gap has historically existed for those without comorbid secondary mental healthcare needs requiring ADHD assessment and support. These patients have historically been directed either through the SLAM national pathway for non-contracted activity, or through EPUT on a spot-purchase basis.
The purpose of the expansion of this service is to commission EPUT to provide a full ADHD assessment and treatment pathway (including the safe titration of specialist medication, robust shared care agreements with GPs, and follow up psychological support for everyday functioning) for all patients irrespective of secondary mental health needs, ensuring an equitable service offer for all through the same local provider.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Essex Partnership University NHS Foundation Trust (EPUT) | - | £337,415 | - |